Molecular Partners AG (MOLN)
5.08
-0.14
(-2.68%)
USD |
NASDAQ |
Dec 20, 16:00
5.18
+0.10
(+1.97%)
After-Hours: 20:00
Molecular Partners Enterprise Value: 16.42M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
AC Immune SA | 77.48M |
CRISPR Therapeutics AG | 1.540B |
Addex Therapeutics Ltd | 4.458M |
NLS Pharmaceutics Ltd | 8.486M |
MoonLake Immunotherapeutics | 2.803B |
Enterprise Value Related Metrics
Net Income (Quarterly) | -18.97M |
Revenue (Quarterly) | 0.7875M |
Total Expenses (Quarterly) | 17.66M |
EPS Diluted (Quarterly) | -0.5666 |
Profit Margin (Quarterly) | -2.41K% |
Earnings Yield | -42.15% |
Normalized Earnings Yield | -39.90 |